Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Securities and Exchange Commission

          - [Release No. 34-92999; File No. SR-NYSEArca-2021-53]

                    On July 23, 2021, NYSE Arca, Inc. (“NYSE Arca”) filed with the Securities and Exchange Commission (“Commission”), pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934 (“Act”) [1]                                          and Rule 19b-4 thereunder,[2]                                          a proposed rule change to list and trade shares of the Teucrium Bitcoin Futures Fund under NYSE Arca Rule 8.200-E, Commentary .02 (Trust Issued Receipts). The proposed rule change was published for comment in the                     **Federal Register**                     on August 11, 2021.[3]                                          The Commission has received comments on the proposed rule change.[4] 

                    Section 19(b)(2) of the Act [5]                                          provides that within 45 days of the publication of notice of the filing of a proposed rule change, or within such longer period up to 90 days (i) as the Commission may designate if it finds such longer period to be appropriate and publishes its reasons for so finding or (ii) as to which the self-regulatory organization consents, the Commission shall either approve the proposed rule change, disapprove the proposed rule change, or institute proceedings to determine whether the proposed rule change should be disapproved. The 45th day after publication of the notice for this proposed rule change is September 25, 2021. The Commission is extending this 45-day time period.                

                    The Commission finds that it is appropriate to designate a longer period within which to take action on the proposed rule change so that it has sufficient time to consider the proposed rule change and the comments received. Accordingly, pursuant to Section 19(b)(2) of the Act,[6]                                          the Commission designates November 9, 2021, as the date by which the Commission shall either approve or disapprove, or                           ( print page 52540)                        institute proceedings to determine whether to disapprove, the proposed rule change (File No. SR-NYSEArca-2021-53).                                    

                        For the Commission, by the Division of Trading and Markets, pursuant to delegated authority.7

J. Matthew DeLesDernier,

Assistant Secretary.

# Footnotes

1.                             15 U.S.C. 78s(b)(1).                    
        Back to Citation      

2.                             17 CFR 240.19b-4.                    
        Back to Citation      

3.                                                     *See*                         Securities Exchange Act Release No. 92573 (August 5, 2021), 86 FR 44062 (August 11, 2021).                    
        Back to Citation      

4.                             Comments received on the proposed rule change are available at:                         *https://www.sec.gov/​comments/​sr-nysearca-2021-53/​srnysearca202153.htm.*
        Back to Citation      

5.                             15 U.S.C. 78s(b)(2).                    
        Back to Citation      

6.                                                     *Id.*
        Back to Citation      

7.                             17 CFR 200.30-3(a)(31).                    
        Back to Citation      

[FR Doc. 2021-20330 Filed 9-20-21; 8:45 am]

BILLING CODE 8011-01-P